v3 Template
U
Until Labs
Healthcare/Biotechnology
Founded
--
Employees
--
Total Funding
$58.0M
Funding Rounds
1
Last Funding
2025-09-22
About Until Labs
Until is a company focused on advancing cryopreservation technology to save lives by ensuring donated organs are not lost to logistics and patients do not die waiting for transplants. Their mission is to extend organ viability from hours to weeks or months, ultimately aiming to eliminate waiting lists and enable whole-body reversible cryopreservation as a bridge to future cures.
Products & Services
Cryopreservation Technology for Organs:Extending the viability of whole human organs from hours to weeks or months to ensure no donated organ is lost and no patient dies waiting.
Whole-Body Reversible Cryopreservation:Developing technology to pause molecular motion, providing patients a bridge to future cures.
Specialties
Cryopreservation
Organ Preservation
Whole-Body Reversible Cryopreservation
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series A T: - FT: Series A |
A: 58000000 MR: - FA: 58 million FAN: 58000000 |
D: 2025-09-22 FD: 2025-09-22 |
3 investors |
Series A
Latest
2025-09-22
$58.0M
3 investors (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Until Labs Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- untillabs.com
- Industries
- Healthcare/Biotechnology
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro